Details of the Drug-Related molecule(s) Interaction Atlas

Z223457004 Drug Info

SCHEMBL18352896; BDBM113297; ZINC12619614; AKOS033814184; MCULE-3787435099; US9695194, 14; Z223457004; 5-(2-methanesulfonylphenyl)-6,11,14-trioxa-4-azatricyclo[8.4.0.0^{3,8}]tetradeca-1,3(8),4,9-tetraen-7-one; 1000928-10-8

Cross-matching ID

PubChem CID

25400536

TTD Drug ID

DMUOZEJ

General Information of Drug (ID: DMUOZEJ)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Chymotrypsin-C (CLCR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
STK296197	DM6KPYL	N. A.	N. A.	Patented	[1]
Z90308237	DMRBFUA	N. A.	N. A.	Patented	[1]
AC1LCOK0	DMFWYKE	N. A.	N. A.	Patented	[1]
PMID12372533C20	DMIW5TY	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Benzoxazinone derivatives for treatment of skin diseases. US9695194.
2	P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3199-202.